Clinical & Neurohormonal Prediction Of Outcome In Atrial Fibrillatio
Recruiting
- Conditions
- Atrial FibrillationCardiovascular - Diseases of the vasculature and circulation including the lymphatic system
- Registration Number
- ACTRN12606000164594
- Lead Sponsor
- Christchurch Cardioendocrine Research Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Atrial fibrillation or flutter on the waiting list for elective DC cardioversion who are welling to participate and capable of attending follow up appointments.
Exclusion Criteria
Any patient who is unable or not welling to consent to be enrolled, and patients who can not attend the follow up appointment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The main aim of this study is to determine whether the hormones atrial natriuretic peptide (ANP) can improve our ability to predict successful cardioversion in atrial fibrillation.[ Measured prior to cardioversion and again at 6 weeks and 12 months afterwards.];The main aim of this study is to determine whether the hormones brain natriuretic peptide (BNP) can improve our ability to predict successful cardioversion in atrial fibrillation.[ Measured prior to cardioversion and again at 6 weeks and 12 months afterwards.]
- Secondary Outcome Measures
Name Time Method In this study we will try to develop a tool that could help in predicting the short and long term outcome post DC cardioversion for the patients with atrial fibrillation. The tool will incorporate the data collected from the different blood tests and imaging results. It will, also, take in consideration the medical background and pharmacological agents commonly used in this condition.Compare between 2 different types of defibrillators used to perform DC cardioversion (Monophasic & Biphasic). The aim will be to identify which type of defibrillator has better outcome and less complications.Record the possible complications associated with atrial fibrillation and its treatment over the follow up period.[ ]